Manufacturer Torrent Pharmaceuticals Limited is recalling 36 additional lots[1] of the blood pressure drug losartan potassium and 68 additional lots of losartan-hydrochlorothiazide combination tablets due to detection of trace amounts of the carcinogen N-Methylnitrosobutyric acid (NMBA) above acceptable daily levels set by the U.S. Food and Drug Administration (FDA).
Information about the nationwide recall, including details on products and lots, is available on the FDA website[2].
To date, there have not been reports of adverse events related to this recall. To learn more about the recall, contact Torrent Pharmaceuticals at (800) 912-9561 or [email protected][3].
Source URL: https://www.diabetesselfmanagement.com/blog/additional-lots-of-losartan-recalled/
Diane Fennell: Diane Fennell was an editor at Diabetes Self-Management magazine from 2003 to 2023. She is the former Editorial Director. (Diane Fennell is not a medical professional.)
Disclaimer of Medical Advice: Statements and opinions expressed on this Web site are those of the authors and not necessarily those of the publishers or advertisers. The information, which comes from qualified medical writers, does not constitute medical advice or recommendation of any kind, and you should not rely on any information contained in such posts or comments to replace consultations with your qualified health care professionals to meet your individual needs.
Copyright ©2025 Diabetes Self-Management unless otherwise noted.